文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

肠上皮特异性闭合蛋白缺失加重脓毒症后肠道通透性与生存恶化

INTESTINAL EPITHELIAL-SPECIFIC OCCLUDIN DELETION WORSENS GUT PERMEABILITY AND SURVIVAL FOLLOWING SEPSIS.
PubMed 文献 · Shock · 2024-12-03
一句话结论临床前脓毒症模型中,肠上皮闭合蛋白缺失仅在脓毒症时加重漏通路通透性、升高炎症因子与菌血症并增加7天死亡率。

该研究在临床前脓毒症模型中,用肠上皮特异性闭合蛋白敲除小鼠与野生型对照,行腹腔内脓毒症造模,部分于预定终点处死做机制研究、部分随访生存。敲除鼠仅在脓毒症状态下肠道通透性显著升高,且局限于漏通路,孔通路与无限制通路无变化;同时紧密连接蛋白ZO-1升高,全身IL-6、MCP-1及菌血症增加,空肠IL-1β、MCP-1及腹腔液MCP-1、IL-17A升高,腹腔细菌水平不变;敲除鼠7天死亡率显著升高。作者认为闭合蛋白在脓毒症时维持肠屏障功能并介导生存中起关键作用,与炎症和菌血症改变相关;作者提出保护闭合蛋白功能的药物可能成为脓毒症治疗的新策略。

要点

  • 肠上皮特异性闭合蛋白敲除鼠仅在脓毒症时肠道通透性显著升高,基线通透性与野生型对照相似。
  • 通透性升高特异于漏通路,孔通路与无限制通路无变化;敲除鼠脓毒症时紧密连接ZO-1水平升高。
  • 敲除鼠全身IL-6、MCP-1升高、菌血症增加,空肠IL-1β、MCP-1及腹腔液MCP-1、IL-17A升高,腹腔细菌水平不变。
  • 脓毒症后敲除鼠7天死亡率显著高于野生型对照。
  • 作者认为保护闭合蛋白功能的药物可能成为脓毒症治疗的新策略。

适用人群与场景

  • 临床前脓毒症模型:肠上皮特异性闭合蛋白敲除小鼠与野生型对照,行腹腔内脓毒症造模。

研究设计与关键结果

  • 研究类型为临床前模型研究,比较肠上皮特异性闭合蛋白敲除小鼠与野生型对照在腹腔内脓毒症后的肠屏障功能与生存。
  • 敲除鼠仅在脓毒症时肠道通透性显著升高,基线通透性与对照相似;通透性改变特异于漏通路,孔通路与无限制通路无变化。
  • 敲除鼠脓毒症时紧密连接ZO-1水平升高,全身IL-6、MCP-1升高,菌血症增加;空肠IL-1β、MCP-1及腹腔液MCP-1、IL-17A升高,腹腔细菌水平不变。
  • 敲除鼠脓毒症后7天死亡率显著高于野生型对照。

证据类型、等级与局限

  • 证据类型:临床前动物模型研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,保护闭合蛋白功能的药物可能成为脓毒症治疗的新策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis induces intestinal hyperpermeability, which is associated with higher mortality. Occludin is a tight junction protein that plays a critical role in regulating disease-associated intestinal barrier loss. This study examined the role of intestinal occludin on gut barrier function and survival in a preclinical model of sepsis. Intestinal epithelial-specific occludin knockout (occludin KO IEC ) mice and wild type controls were subjected to intra-abdominal sepsis and sacrificed at predetermined endpoints for mechanistic studies or followed for survival. Occludin KO IEC mice had a significant increase in intestinal permeability, which was induced only in the setting of sepsis as knockout mice and control mice had similar baseline permeability. The worsened barrier was specific to the leak pathway of permeability, without changes in either the pore or unrestricted pathways. Increased sepsis-induced permeability was associated with increased levels of the tight junction ZO-1 in occludin KO IEC mice. Occludin KO IEC mice also had significant increases in systemic cytokines IL-6 and MCP-1 and increased bacteremia. Furthermore, occludin KO IEC mice had higher levels of jejunal IL-1β and MCP-1 as well as increased MCP-1 and IL-17A in the peritoneal fluid although peritoneal bacteria levels were unchanged. Notably, 7-day mortality was significantly higher in occludin KO IEC mice following sepsis. Occludin thus plays a critical role in preserving gut barrier function and mediating survival during sepsis, associated with alterations in inflammation and bacteremia. Agents that preserve occludin function may represent a new therapeutic strategy in the treatment of sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Yumoto T, Oami T, Liang Z, et al. INTESTINAL EPITHELIAL-SPECIFIC OCCLUDIN DELETION WORSENS GUT PERMEABILITY AND SURVIVAL FOLLOWING SEPSIS. Shock. 2024. PMID: 39637366. doi:10.1097/SHK.0000000000002531

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。